This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2001 May-Jun;35(3):16-20.

Pregnancy and the drug dilemma

PMID: 11458544

Free article

Pregnancy and the drug dilemma

M Meadows. FDA Consum. 2001 May-Jun.

Free article

. 2001 May-Jun;35(3):16-20.

Author

PMID: 11458544

No abstract available

PubMed Disclaimer

Similar articles

Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
Kelsey FO. Kelsey FO. Prog Clin Biol Res. 1985;163C:155-9. Prog Clin Biol Res. 1985. PMID: 3991617 No abstract available.
Drug and other hazards to the fetus and newborn.
Freeman MM, Finkel MJ. Freeman MM, et al. Prog Clin Biol Res. 1980;36:67-72. Prog Clin Biol Res. 1980. PMID: 7403181 No abstract available.
FDA problems with medications in the marketplace: IV. Drugs and the unborn.
Archambault GF. Archambault GF. Hosp Formul. 1977 Jan;12(1):56. Hosp Formul. 1977. PMID: 10236016 No abstract available.
An overview of over the counter drugs in pregnancy and lactation.
Das BP, Joshi M, Pant CR. Das BP, et al. Kathmandu Univ Med J (KUMJ). 2006 Oct-Dec;4(4):545-51. Kathmandu Univ Med J (KUMJ). 2006. PMID: 18603972 Review.
Prescribing for the pregnant patient.
Mehta N, Chen K, Powrie RO. Mehta N, et al. Cleve Clin J Med. 2014 Jun;81(6):367-72. doi: 10.3949/ccjm.81a.13124. Cleve Clin J Med. 2014. PMID: 24891538 Review.

See all similar articles

Cited by

Drug use in pregnancy; a point to ponder!
Sachdeva P, Patel BG, Patel BK. Sachdeva P, et al. Indian J Pharm Sci. 2009 Jan;71(1):1-7. doi: 10.4103/0250-474X.51941. Indian J Pharm Sci. 2009. PMID: 20177448 Free PMC article.
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.
Ettlin RA, Kuroda J, Plassmann S, Prentice DE. Ettlin RA, et al. J Toxicol Pathol. 2010 Dec;23(4):189-211. doi: 10.1293/tox.23.189. Epub 2010 Dec 16. J Toxicol Pathol. 2010. PMID: 22272031 Free PMC article.
Successful drug development despite adverse preclinical findings part 2: examples.
Ettlin RA, Kuroda J, Plassmann S, Hayashi M, Prentice DE. Ettlin RA, et al. J Toxicol Pathol. 2010 Dec;23(4):213-34. doi: 10.1293/tox.23.213. Epub 2010 Dec 16. J Toxicol Pathol. 2010. PMID: 22272032 Free PMC article.
A systematic review of possible serious adverse health effects of nicotine replacement therapy.
Lee PN, Fariss MW. Lee PN, et al. Arch Toxicol. 2017 Apr;91(4):1565-1594. doi: 10.1007/s00204-016-1856-y. Epub 2016 Oct 3. Arch Toxicol. 2017. PMID: 27699443 Free PMC article.
Creating an ignorance-base: Exploring known unknowns in the scientific literature.
Boguslav MR, Salem NM, White EK, Sullivan KJ, Bada M, Hernandez TL, Leach SM, Hunter LE. Boguslav MR, et al. J Biomed Inform. 2023 Jul;143:104405. doi: 10.1016/j.jbi.2023.104405. Epub 2023 Jun 1. J Biomed Inform. 2023. PMID: 37270143 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- US Food & Drug Administration
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information